BAGSVAERD, DENMARK--(Marketwire - April 02, 2012) - In continuation of the company’s announcements dated 2 November 2011 and 2 February 2012 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S (NYSE: NVO) and its wholly-owned affiliates on 31 March 2012 owned 27,329,627 of its own B shares of DKK 1, corresponding to a total nominal value of DKK 27,329,627 or 4.71% of the total share capital.
Company Anouncement no 21 2012:
http://hugin.info/2013/R/1599447/504659.pdf
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Thomson Reuters ONE [HUG#1599447]
Media:
Anne Margrethe Hauge
Tel: (+45) 4442 3450
Email Contact
In North America:
Ken Inchausti
Tel: (+1) 609 514 8316
Email Contact
Investors:
Klaus Bulow Davidsen
Tel: (+45) 4442 3176
Email Contact
Frank Daniel Mersebach
Tel: (+45) 4442 0604
Email Contact
Lars Borup Jacobsen
Tel: (+45) 3075 3479
Email Contact
Jannick Lindegaard
Tel: (+1) 609 786 4575
Email Contact